Silo Pharma, Inc. (SILO) stock
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.84−0.07 (-3.66%)
Close on Nov 13, 2026Market cap $2.92MP/E –Yield –
Silo Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Silo Pharma's enterprise value was -$3.15M on Nov 11, 2026, against -$1.00M a year earlier. Over the last 5 years it ranged from -$5.29M to $10.90M, with a median of -$2.07M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.15M | – |
| 2025 | Dec 31, 2025 | -$2.31M | – |
| 2024 | Dec 31, 2024 | -$4.02M | – |
| 2023 | Dec 29, 2023 | -$4.29M | – |
| 2022 | Dec 30, 2022 | -$1.71M | -145.0% |
| 2021 | Dec 31, 2021 | $3.79M | -89.0% |
| 2020 | Dec 31, 2020 | $34.49M | – |
See a number that looks wrong?